IP Library Granted Patent US 10,780,054
Granted Patent B2
US 10,780,054 · App. 15/566,980 · Granted Sep 22, 2020

Lyophilization of RNA

Inventors: Thomas Ketterer (Gomaringen, DE); Thorsten Mutzke (Reutlingen, DE); Michael Wiggenhorn (Munich, DE); Frank Schaubhut (Germering, DE); Florian Von Der Mülbe (Stuttgart, DE)
Assignee: CureVac Real Estate GmbH
A61K9/19A61K31/7105A61K47/549A61K47/64C12Q1/6806C12N15/1003
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,780,054
App. No.
15/566,980
Granted
Sep 22, 2020
Kind
B2
Abstract

The present invention is directed to the field of RNA formulation, in particular to lyophilization of RNA. The invention provides a method for lyophilization of RNA. The present invention further concerns a lyophilized composition obtainable by the inventive method, a pharmaceutical composition, a vaccine and a kit or kit of parts. Moreover, the present invention provides a novel use of a lyoprotectant for lyophilizing RNA, the use of the inventive method in the manufacture of a medicament as well as the first and second medical use of the composition obtainable by the inventive method, the pharmaceutical composition, the vaccine or the kit or kit of parts according to the invention.

Claims (31)

1. A method for lyophilizing long-chain RNA, wherein the method comprises the following steps:

a) providing a liquid having a glass transition temperature comprising at least one long-chain RNA and at least one lyoprotectant, wherein the glass transition temperature of the liquid is in a range from −15° C. to −50° C.;

b) introducing the liquid provided into a freeze drying chamber of a freeze dryer;

c) cooling the liquid to a freezing temperature, wherein the cooling is performed at a defined cooling rate;

d) freezing the liquid having the glass transition temperature at the freezing temperature in order to obtain a frozen liquid, wherein the freezing temperature is in a range from 0.5° C. to 25° C. below the glass transition temperature of the liquid provided in step a);

e) reducing the pressure in the freeze drying chamber to a pressure below atmospheric pressure;

f) drying the frozen liquid obtained in step d) in order to obtain a lyophilized composition comprising the at least one long-chain RNA and at least one lyoprotectant, wherein drying comprises heating the frozen liquid obtained in step d) to a drying temperature, wherein the heating is performed at a defined heating rate, wherein the defined heating rate is in a range from 0.1° C./h to 20° C./h; and

g) equilibrating the pressure in the freeze drying chamber to atmospheric pressure and removing the lyophilized composition comprising the at least one long-chain RNA and the at least one lyoprotectant obtained in step f) from the freeze drying chamber.

2. The method of claim 1 , wherein the at least one long-chain RNA comprises from 100 to 50,000 nucleotides.

3. The method of claim 1 , wherein the at least one long-chain RNA is not a viral RNA or an RNA that is derived from a viral RNA.

4. The method of claim 1 , wherein the drying temperature is lower than the glass transition temperature of the liquid.

5. The method of claim 1 , wherein the drying temperature is in a range from −40° C. to 40° C.

6. The method of claim 1 , wherein the liquid further comprises at least one cationic or polycationic compound.

7. The method of claim 6 , wherein the cationic or polycationic compound is a cationic or polycationic peptide or protein.

8. The method of claim 6 , wherein the at least one long-chain RNA and the at least one cationic or polycationic compound are present in a complex.

9. The method of claim 1 , wherein the at least one long-chain RNA comprises at least one coding region.

10. The method of claim 1 , wherein the at least one long-chain RNA is an mRNA.

11. The method of claim 1 , wherein the lyoprotectant is a carbohydrate compound, preferably selected from the group consisting of mannitol, sucrose, glucose, mannose, trehalose.

12. The method of claim 1 , wherein the concentration of the lyoprotectant in the liquid provided in step a) is in a range from 1 to 20% (w/w).

13. The method of claim 1 , wherein the concentration of the at least one long-chain RNA in the liquid provided in step a) is in a range from 0.1 to 10 g/l.

14. The method according to claim 1 , wherein the glass transition temperature of the liquid is in a range from −25° C. to −40° C.

15. The method according to claim 1 , wherein the freezing temperature is in a range from −50° C. to −35° C.

16. The method of claim 1 , wherein the cooling rate in step c) is in a range from 0.1° C./min to 2° C./min.

17. A method for lyophilizing single-stranded RNA, wherein the method comprises the following steps:

a) providing a liquid having a glass transition temperature comprising at least one single-stranded RNA and at least one lyoprotectant, wherein the glass transition temperature of the liquid is in a range from −15° C. to −50° C.;

b) introducing the liquid provided into a freeze drying chamber of a freeze dryer;

c) cooling the liquid to a freezing temperature, wherein the cooling is performed at a defined cooling rate;

d) freezing the liquid having the glass transition temperature at the freezing temperature in order to obtain a frozen liquid having the glass transition temperature, wherein the freezing temperature is in a range from 0.5° C. to 25° C. below the glass transition temperature of the liquid provided in step a);

e) reducing the pressure in the freeze drying chamber to a pressure below atmospheric pressure;

f) drying the frozen liquid obtained in step d) in order to obtain a lyophilized composition comprising the at least one single-stranded RNA and at least one lyoprotectant, wherein drying comprises heating the frozen liquid obtained in step d) to a drying temperature, wherein the heating is performed at a defined heating rate, wherein the defined heating rate is in a range from 0.1° C./h to 20° C./h; and

g) equilibrating the pressure in the freeze drying chamber to atmospheric pressure and removing the lyophilized composition comprising the at least one single-stranded RNA and the at least one lyoprotectant obtained in step f) from the freeze drying chamber.

Assignments (3)
CHANGE OF NAME Recorded Aug 24, 2022
From: CUREVAC REAL ESTATE GMBH
To: CUREVAC MANUFACTURING GMBH
Reel/Frame 061314/0237 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2020
From: CUREVAC AG
To: CUREVAC REAL ESTATE GMBH
Reel/Frame 051487/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2018
From: KETTERER, THOMAS; MUTZKE, THORSTEN; WIGGENHORN, MICHAEL; SCHAUBHUT, FRANK; VON DER MÜLBE, FLORIAN
To: CUREVAC AG
Reel/Frame 045889/0445 →
Priority Claims (1)
WO PCT/EP2015/000818 · Apr 17, 2015 · international
Continuity (1)
Related Publication 20180243219A1 · Aug 30, 2018
Cited By (22)
US 12,194,148 US 12,194,157 US 12,201,680 US 12,208,165 US 12,221,605 US 12,227,549 US 12,240,873 US 12,311,061 US 12,318,444 US 12,318,486 US 12,337,031 US 12,385,088 US 12,409,149 US 12,442,005 US 12,460,204 US 12,465,654 US 12,514,918 US 12,527,856 US 12,528,855 US 12,533,422 US 12,618,060 US 12,649,914